Transcutaneous Electrical Nerve
Stimulation (TENS), Neuromuscular Electrical Stimulation (NMES/EMS), Trigeminal
Nerve Stimulation (TNS), and Transcranial Magnetic Stimulation (TMS) are some
of the non-invasive pain management approaches.
Statistics:
The global Pain
Management Devices Market is estimated to account for US$ 17,004.2 Mn in
terms of value by the end of 2027.
Global Pain Management Devices
Market: Drivers
Increasing investment in pain
management devices is expected to propel growth of the global pain management
devices market over the forecast period. For instance, in June 2020, CereVasc,
Inc., a developer of a minimally invasive implant for the treatment of
hydrocephalus raised US$ 43 million to help launch first-in-human clinical
testing.
Global Pain Management Devices
Market: Opportunities
Increasing prevalence of diabetes
is expected to offer lucrative growth opportunities for players in the global
pain management devices market. For instance, according to the study, “Global
and regional diabetes prevalence estimates for 2019 and projections for 2030
and 2045: Results from the International Diabetes Federation Diabetes Atlas,
9th edition”, published in the journal Diabetes Research and Clinical Practice,
in September 2019, 463 million people are expected to suffer from diabetes in
2019 worldwide and the number is expected to reach 578 million by 2030 and 700
million by 2045.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/3947
Global Pain Management Devices
Market: Restraints
Stimulators that use electrical
currents to block pain signals before they reach the brain prove sometimes
fatal and may lead to medical device injuries. Such scenario is expected to
hinder growth of the market.
Key Takeaways:
The global pain management devices
market was valued at US$ 5,745.0 Mn in 2019 and is forecast to reach a value of
US$ 17,004.2 Mn by 2027 at a CAGR of 14.6% between 2020 and 2027. Increasing
incidence and prevalence of chronic diseases is expected to increase demand for
pain management devices during the forecast period.
Neurostimulation Devices segment
held dominant position in the global pain management devices market in 2019,
accounting for 56.2% share in terms of value, followed by radiofrequency
ablation and analgesic pumps, respectively. Increasing approval and launch of
new devices is expected to propel the segment growth during the forecast
period.
Market Trends
Increasing prevalence of
arthritis is boosting growth of the market. For instance, According to the
Centers for Disease Control and Prevention (CDC)’s May 2019 report, an
estimated 54.4 million US adults have diagnosed arthritis, which accounted for
around 1 in 4 people in the U.S.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/pain-management-devices-market-3947
Major players in the market are
focused on approval and launch of new devices to expand their product
portfolio. For instance, in January 2020, Axonics Modulation Technologies, Inc.
received the U.S. FDA approval for its second-generation programmer for its
r-SNM sacral neuromodulation system. The new programmer is designed to program
the Axonics external trial neurostimulator and the implantable neurostimulator
in the procedure and post-operative environments.
Global Pain Management Devices Market:
Competitive Landscape
Major players operating in the
global pain management devices market include, Baxter International Inc., B.
Braun Melsungen AG, Boston Scientific Corporation, Codman and Shurtleff, Inc.,
DJO Global LLC, NeuroMetrix, Inc., Hospira Inc., Kimberly-Clark Corporation,
Medtronic, Plc, Smiths Medical, Axonics Modulation Technologies, Inc.,
NeuroSigma, Inc., and Abbott
Global Pain Management Devices
Market: Key Developments
April 2020: NeuroMetrix, Inc.
announced that Quell technology has been selected for use in a large,
NIH-funded, randomized, pragmatic clinical trial of TENS for fibromyalgia.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/3947
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment